List view / Grid view
22 June 2015 | By Victoria White
New studies have demonstrated techniques for stimulating animal cells to produce antibodies that could stop HIV from infecting human cells in the laboratory...
4 June 2015 | By Victoria White
When the T cells of your immune system are forced to deal over time with cancer or a chronic infection, they can develop "T cell exhaustion"...
27 May 2015 | By Victoria White
An international team of scientists has identified the molecular “lock” that the deadly Ebola virus must pick to gain entry to cells...
11 May 2015 | By Victoria White
UNC-Chapel Hill and GSK have announced the creation of a dedicated HIV Cure centre and a new company that will focus on discovering a cure for HIV/AIDS...
20 April 2015 | By Victoria White
Mymetics is leading a consortium to development thermo stable and cold-chain independent nano-pharmaceutical virosome-based vaccine candidates.
17 April 2015 | By Victoria White
A team lead by IAVI scientists has defined an additional way to generate trimers that could benefit future clinical development of HIV vaccines...
26 February 2015 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced data supporting the clinical development of BMS-955176, an investigational component designed to prevent the maturation of HIV-1...
5 February 2015 | By The Institute of Cancer Research
Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown...
2 February 2015 | By ABIVAX
ABIVAX today announced that enrollment has been initiated and the first HIV positive patient dosed in a Phase IIa clinical trial of ABX464...
9 January 2015 | By Roche
FDA Approves Roche’s Blood Screening Assay for Simultaneous Detection and Identification of Three Major Viral Targets. cobas TaqScreen MPX Test, v2.0 offers enhanced sensitivity and workflow advantages...
5 January 2015 | By Pfizer
Acquisition provides Pfizer with a preclinical CMV vaccine candidate...
1 December 2014 | By ABIVAX
ABIVAX, a leading clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, announced the successful completion of its Phase 1 first-in-man study of ABX464, which has been designed to potentially deliver a number of important clinical benefits when treating patients with HIV.,,
21 November 2014 | By The Institute of Cancer Research
Professor Paul Workman sets out his vision for cancer drug discovery as he is appointed Chief Executive of The Institute of Cancer Research, London
19 November 2014 | By Nosopharm
These high-profile experts will help with the quick and safe launch of the preclinical development program for a new class of antibiotics...
13 November 2014 | By Bristol-Myers Squibb
The Partnering for Cure faculty of experts announced the four recipients of awards for research proposals that will help to provide insights into the pathophysiology of viral diseases and the potential development of cure strategies in HIV, hepatitis B (HBV) and hepatitis C (HCV)...
